Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
May 24 2022 - 8:32AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
under
the Securities Exchange Act of 1934
For
the month of May 2022
(Report No. 2)
Commission
file number: 001-38041
SCISPARC
LTD.
(Translation
of registrant’s name into English)
20
Raul Wallenberg Street, Tower A,
Tel
Aviv 6971916 Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
CONTENTS
On
May 24, 2022, SciSparc Ltd. (the “Company”) issued a press release titled “SciSparc and Clearmind Medicine Inc. Collaboration
Yields Positive Results for its Psychedelic Combination Treatment”. A copy of this press release is furnished herewith as Exhibit
99.1.
The
press release attached as Exhibit 99.1 is incorporated by reference into the registration statements on Form F-3 (File No. 333-233417
and File No. 333-248670) and on Form S-8 (File No. 333-225773) of the Company, filed with the Securities and Exchange Commission, to
be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently
filed or furnished.
EXHIBIT
INDEX
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
SciSparc Ltd. |
|
|
Date: May 24, 2022 |
By: |
/s/
Oz Adler |
|
|
Name: |
Oz Adler |
|
|
Title: |
Chief Executive Officer
&
Chief Financial Officer |
3
Therapix Biosciences (NASDAQ:TRPX)
Historical Stock Chart
From Sep 2024 to Oct 2024
Therapix Biosciences (NASDAQ:TRPX)
Historical Stock Chart
From Oct 2023 to Oct 2024